Hepatitis B vaccination and reduced risk of primary liver cancer among male adults: A cohort study in Korea

International Journal of Epidemiology

Volumn 27, Issue 2, 1998, Pages 316-319

  Lee, Moo Song ^a   Kim, Dong Hyun ^b   Kim, Heon ^c   Lee, Hyo Suk ^d   Kim, Chung Yong ^d   Park, Tae Soo ^e   Yoo, Keun Young ^d   Park, Byung Joo ^d   Ahn, Yoon Ok ^d  

^a University of Ulsan College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Chungbuk National University College of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

^e Korea Deposit Insurance Corporation   (South Korea)

Author keywords

Cohort study; Hepatitis B virus; Prevention; Primary liver cancer; Vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; FOLLOW UP; HEPATITIS B; HUMAN; KOREA; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VACCINATION;

ADULT; COHORT STUDIES; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INCIDENCE; KOREA; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RISK; VACCINATION;

EID: 0031947150     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.2.316     Document Type: Article

References (19)

1. WHO Scientific Group. Prevention of primary liver cancer: Report on a meeting of a WHO Scientific Group. Lancet 1983;ii:463-65.
2. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. Lancet 1981;ii:1129-33.
3. Ahn YO, Kim YS, Lee MS, Shin MH. Hepatitis B virus infection rate among Koreans. Seoul J Med 1992;33:105-14.
4. Ahn YO, Park BJ, Yoo KY, Lee HS, Kim CY, Shigematsu T. Incidence estimation of primary liver cancer among Koreans. J Korean Cancer Res Assoc 1989;21:241-48.
5. Yoo KY, Lee MS, Lee Y, Choi BY, Kim H, Kim YS. A stochastic analysis of the force of infection by hepatitis B virus in Korea. Korean J Epidemiol 1992;14:128-37.
6. Kim CY, Kim JW, Lee HS, Yoon YB, Song IS. Natural history and survival rate of hepatitis B virus infection in Korea. Korean J Med 1994;46:168-80.
7. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993;262:369-70.
8. Han BS, Kim IS, Suh I. A study of the seroconversion rates of anti HBs and the duration of anti Hbs persistence after hepatitis B vaccination. Korean J Epidemiol 1989;11:215-31.
9. Yoo KY, Kim H, Lee MS et al. A reconstructed cohort study on the hepatitis B virus infection as a risk factor of liver cancer in Korea. J Korean Med Sci 1991;6:319-24.
10. Holford TR. The anlysis of rates and of survivorship using log-linear models. Biometrics 1980;36:299-305.
11. The GLIM Working Party. The Generalised Linear Interactive Modelling System Release 3.77. Oxford, UK: Numerical Algorithms Group Ltd, 1987.
12. Polesky HF, Hanson MR. Comparison of viral hepatitis marker test methods based on AABB-CAP survey data. Am J Clin Pathol 1981; 76:521S-24S.
13. Yoo KY. Predictability of the test methods used in the detection for hepatitis B virus infection in a defined population. Seoul J Med 1988;29:143-48.
14. Park BJ. A study of the validity of passive hemagglutination (PHA) test for HBsAb. Korean J Prev Med 1987;20:114-19.
15. Park BJ, Ahn YO. Cohort study on the asymotomatic chronic carrier rate of hepatitis B virus among male adults in Korea. Korean J Epidemiol 1989;11:263-73.
16. London WT. Primary hepatocellular carcinoma-etiology, pathogenesis, and prevention. Hum Pathol 1981;12:1085-97.
17. Carmeli Y, De-Medina T. Serious hepatitis B vaccine adverse reactions, are they immune-mediated? [letter]. Vaccine 1993;11:1358-59.
18. Manifold IH, Triger DR, Underwood JC. Kupffer-cell depletion in chronic liver disease: implications for hepatic carcinogenesis. Lancet 1983;ii:431-33.
19. Chen SH, Hu CP, Lee CK, Chang C. Immune reactions against hepatitis B viral antigens lead to the rejection of hepatocellular carcinoma in BALB/c mice. Cancer Res 1993;53:4648-51.